OPA1 and hereditary disease: Genetic disorders with imbalances of elongation/fragmentation are known to impact in vivo SKM oxidative capacity, such as in dominant optic atrophy due to mutations of the pro‐fusion gene Opa1 (Lodi et al., 2011).